fashion -WSS

fashion

author：leisure time 2025-09-30 16:28:21 - browse：396

In the center, three researchers examine a DNA helix. Two people stand in the front, one puts an apple into a capsule containing vegetables, the other holds a check list while standing next to a pile of medicines. On the right side, a scientist injects into mitochondria while another takes notes. A person behind the duo looks at a projection of a brain. On the left side, a client looks at a heart projection from a device held by a robot — biotech coverage from STAT — Adobe

When it comes to bringing an experimental drug to market and selling it, Novo Nordisk, the maker of the weight loss drug Wegovy, is tops, according to a new analysis.

But if you want to invent lots of potential drugs that could eventually reach the market, you’d be far better off with Johnson & Johnson, Merck, or AstraZeneca.

The analysis, the 13th edition of the Pharmaceutical Innovation and Invention Index, was produced by the consultancy Idea Pharma and released Thursday at the STAT Breakthrough Summit in San Francisco.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Flint parents haunted by uncertainty, fears of lead poisoning

hotspot

WSS

Study links childhood stress with decline in older age

Stem cell treatment guidelines are released by FDA

Crinetics acromegaly drug succeeds in late

How to protect patients from sexual assault

Chris Christie meets with Zelenskyy during Ukraine trip

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

focus

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Wikipedia

Peter Hotez and the public health issue of online harassment

Amazon on where the company's health care bets are headed next

Affirmative action in medical school literally saved lives

The (many) problems with a new study criticizing cancer screening

Novavax promises a turnaround & Lilly roils the obesity market

Heart disease in astronauts blamed on cosmic radiation

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

House transparency, PBM reform bill gains bipartisan support

In Memoriam: Notable people who died in 2023

NIH nominee Bertagnolli will get October confirmation hearing

hotspot

FDA approves Sage Therapeutics’ rapid

What drug price negotiations mean for Medicare Part D

Late stage cancers on the rise after pandemic delayed screenings

NIH nominee Bertagnolli will get October confirmation hearing

CDC recommends RSV monoclonal antibody for infants

A controversial new treatment promises to make little people taller

explore

explore

hotspot

focus